Christina Rossi - 03 Nov 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
03 Nov 2021
Net transactions value
-$56,644
Form type
4
Filing time
23 Mar 2022, 16:05:13 UTC
Previous filing
21 Oct 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale $56,644 -511 -1.1% $110.85 43,968 03 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 The amount of securities beneficially owned by the Reporting Person, as reported in Forms 4 filed by the Reporting Person subsequent to the Transaction Date but prior to the date of this Form 4, did not reflect this sell to cover transaction.